Author:
Longo Fabiana,De Ritis Daniele,Miluzio Annarita,Fraticelli Davide,Baets Jonathan,Scarlato Marina,Santorelli Filippo M.,Biffo Stefano,Maltecca Francesca
Abstract
Background and ObjectivesAutosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is caused by variations in SACS gene encoding sacsin, a huge multimodular protein of unknown function. More than 200 SACS variations have been described worldwide to date. Because ARSACS presents phenotypic variability, previous empirical studies attempted to correlate the nature and position of SACS variations with the age at onset or with disease severity, although not considering the effect of the various variations on protein stability. In this work, we studied genotype-phenotype correlation in ARSACS at a functional level.MethodsWe analyzed a large set of skin fibroblasts derived from patients with ARSACS, including both new and already published cases, carrying variations of different types affecting diverse domains of the protein.ResultsWe found that sacsin is almost absent in patients with ARSACS, regardless of the nature of the variation. As expected, we did not detect sacsin in patients with truncating variations. We found it strikingly reduced or absent also in compound heterozygotes carrying diverse missense variations. In this case, we excluded SACS mRNA decay, defective translation, or faster posttranslational degradation as possible causes of protein reduction. Conversely, our results demonstrate that nascent mutant sacsin protein undergoes cotranslational ubiquitination and degradation.DiscussionOur results provide a mechanistic explanation for the lack of genotype-phenotype correlation in ARSACS. We also propose a new and unambiguous criterion for ARSACS diagnosis that is based on the evaluation of sacsin level. Last, we identified preemptive degradation of a mutant protein as a novel cause of a human disease.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference45 articles.
1. OMIM. Accessed March 15, 2021. www.omim.org/
2. Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Bouchard;Can J Neurol Sci,1978
3. Vermeer S , van de Warrenburg BP , Kamsteeg EJ , Brais B , Synofzik M . Arsacs. In: Adam MP , Ardinger HH , Pagon RA , et al , eds. GeneReviews®. University of Washington, Seattle; 1993–2020.
4. Mutations in SACS cause atypical and late-onset forms of ARSACS
5. Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献